Electrophysiology Market by Product (EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, Wolff-Parkinson-White Syndrome) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

September 2016 | 120 pages | ID: E15F9D301DFEN
Allied Market Research

Abstracts

Electrophysiology (EP) is the branch of science that deals with the study of electric activity in the human body. EP devices are used to treat abnormal electrical properties of cell and tissues that leads to various cardiac arrhythmias. Innovative EP technologies are developed to improve the diagnosis and treatment of life-threatening conditions, such as atrial fibrillation (AF), atrial flutter, Wolff-Parkinson-White Syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and other cardiac arrhythmias.
The growing incidence of AF-one of the most common heart rhythm disorder or arrhythmia is the prime factor to drive the growth of the EP market. In addition, cardiovascular diseases treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. Increase in baby boomer generation with high-risk of targeted diseases and increase in adoption of EP catheter ablation propels the market growth. Moreover, rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, novel diagnostic catheters, and laser ablation systems), has fuel the demand for EP devices across various settings in EP labs. However, stringent government regulations, high cost of the advanced EP devices, preference to pharmaceutical interventions (drugs) over EP treatment devices and dearth of skilled & experienced electrophysiologists are set to restrain the market growth. The world electrophysiology market is projected reach $8,271 Million by 2022, growing at a CAGR of 13.4% during 2016 to 2022, from 2015 market value of $3,420 million.
The world electrophysiology market is segmented on the basis of product, indication and geography. Based on product, the market is segmented primarily into EP ablation catheters, EP laboratory devices, EP diagnostic catheters, access devices and others. EP ablation catheter is further sub-segmented into cryoablation EP catheters, radiofrequency EP catheters, microwave EP catheters, laser EP catheters, and navigational advanced mapping accessories. Radiofrequency EP catheters are further categorized into conventional and irrigated-tip ablation catheters. Radiofrequency EP catheters has the largest market share, owing to high prevalence rate of atrial fibrillation and technological advancements in RF ablation such as irrigated tip catheters, which is found to be superior (in terms of efficacy and safety) than conventional RF ablation. Cryoablation EP catheter market is expected to grow at the fastest rate due to technological advancements in this sector and preferred option by the physicians to ablate abnormal cardiac cells, where procedural precision is crucial. In addition, EP X-Ray Systems holds remarkable share in the EP market and poised to grow at steady pace due to the growing demand in EP labs to enhance the ability to perform complex procedures with confidence. Moreover, steerable diagnostic catheters are the driving force behind the growth of conventional EP diagnostic catheters attributed to the rising adoption of these devices gaining FDA approval for the treatment of AF. Based on indication, the market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-white syndrome (WPW) and others. Atrial fibrillation holds the highest share in the indication segment owing to the high incident rate and the most common type of cardiac arrhythmia in clinical practice.
The geographical segmentation of the market includes North America, Europe, Asia-Pacific, and LAMEA. In 2015, North America accounted for the largest market share of 36.2% in the EP market and estimated to retain its dominant position throughout the forecast period. The growth in this region is mainly due to the factors such as product innovations, sophisticated healthcare infrastructure, U.S. – being the target area for the top players in the market owing to high prevalence rate of AF. Nevertheless, Asia Pacific region is expected to emerge as the area with maximum growth potential due to the rising number of cardiovascular diseases, presence of high unmet needs, and increased focus of key players towards emerging markets such as China and India, and increased healthcare spending for the development of improved healthcare infrastructure.
Product development and launch is the mostly adopted strategy in the electrophysiology market followed by acquisition. The report provides a comprehensive analysis of the key players that operate in the world Electrophysiology market such as:

• St. Jude Medical, Inc.
• Boston Scientific Corporation,
• Biosense Webster, Inc. (a Johnson & Johnson Company)
• Medtronic, Inc.
• Siemens AG
• GE Healthcare (a division of General Electric Company.)
• Philips Healthcare (a division of Koninklijke Philips N.V.)
• Biotronik SE & Co.KG
• Abbott Laboratories.
• Microport Scientific Corporation

KEY MARKET BENEFITS

• The study provides an in-depth analysis of the world electrophysiology market with current trends and future estimations to elucidate the imminent investment pockets.
• The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the market, by product, helps understand various types of devices used for the treatment of atrial fibrillation, atrial flutter, Wolff-Parkinson-White Syndrome, atrioventricular nodal reentry tachycardia, and other cardiac arrhythmias.
• Competitive intelligence highlights the business practices followed by the leading market players across various geographies.
• Porter’s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.

KEY MARKET SEGMENTS

By Product

• EP Ablation Catheters
• Cryoablation EP Catheters
• Radiofrequency Ablation Catheters
• Irrigated-tip Radiofrequency Ablation Catheters
• Conventional Radiofrequency Ablation Catheters
• Microwave Ablation Systems
• Laser Ablation Systems
• Navigational Advanced Mapping Accessories
• EP Laboratory Devices
• EP X-Ray Systems
• 3D Mapping Systems
• EP Recording Systems
• EP Remote Steering Systems
• Others
• EP Diagnostic Catheters
• Conventional EP Diagnostic Catheters
• Steerable Diagnostic Catheters
• Fixed Diagnostic Catheters
• Advanced EP Diagnostic Catheters
• Ultrasound EP Diagnostic Catheters
• Access Devices
• Others

By Indication

• Atrial Fibrillation (AF)
• Atrial Flutter
• Wolff-Parkinson-White Syndrome (WPW)
• Atrioventricular Nodal Reentry Tachycardia (AVNRT)
• Others

By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• U.K.
• France
• Germany
• Italy
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• Egypt
• Israel
• South Africa
• Rest of LAMEA

Contents

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key market benefits
1.3 Key market segments:
1.4 Research methodology
  1.4.1 Secondary research
  1.4.2 Primary research
  1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings
  3.2.1 Top investment pockets
  3.2.2 Top winning strategies
3.3 Porters five forces analysis
  3.3.1 Bargaining power of suppliers
  3.3.2 Bargaining power of buyers
  3.3.3 Threats of new entrants
  3.3.4 Threats of substitutes
  3.3.5 High intensity of rivalry
3.4 Market share analysis, 2015
3.5 Market dynamics
  3.5.1 Drivers
    3.5.1.1 Technological advancements in EP Devices
    3.5.1.2 Growing incidence of AF due to increasing baby booming generation
    3.5.1.3 Unmet medical needs with upcoming treartment modifictions
    3.5.1.4 Increasing preference of EP catheter ablation for cardiac arrhythmia treatment
  3.5.2 Restraints
    3.5.2.1 High cost of the EP Device
    3.5.2.2 Dearth of skilled electrophysiologists
    3.5.2.3 Preference to pharmaceutical interventions (drugs) over EP treatment devices
  3.5.3 Opportunities
    3.5.3.1 Lucrative opportunities in emerging economies
    3.5.3.2 Rising awareness regarding the EP technologies

CHAPTER 4 WORLD ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2014-2022, ($MILLION)

4.1 Overview
  4.1.1 Market size and forecast
4.2 EP ablation catheters
  4.2.1 Key market trends
  4.2.2 Key growth factors and opportunities
  4.2.3 Market size and forecast
  4.2.4 Cryoablation EP catheters
    4.2.4.1 Market size and forecast
  4.2.5 Radiofrequency (RF) ablation catheters
    4.2.5.1 Market size and forecast
    4.2.5.2 Conventional RF ablation catheters
      4.2.5.2.1 MARKET SIZE AND FORECAST
    4.2.5.3 Irrigated-tip RF ablation catheters
      4.2.5.3.1 MARKET SIZE AND FORECAST
  4.2.6 Microwave ablation (MWA) systems
    4.2.6.1 Market size and forecast
  4.2.7 Laser ablation systems
    4.2.7.1 Market size and forecast
  4.2.8 Navigational advanced mapping accessories
    4.2.8.1 Market size and forecast
4.3 EP laboratory devices
  4.3.1 Key market trends
  4.3.2 Key growth factors and opportunities
  4.3.3 Market size and forecast
  4.3.4 3D mapping systems
    4.3.4.1 Market size and forecast
  4.3.5 EP recording systems
    4.3.5.1 Market size and forecast
  4.3.6 EP X-Ray systems
    4.3.6.1 Market size and forecast
  4.3.7 EP remote steering systems
    4.3.7.1 Market size and forecast
  4.3.8 Others
    4.3.8.1 Market size and forecast
4.4 Electrophysiology diagnostic catheters
  4.4.1 Key market trends
  4.4.2 Key growth factors and opportunities
  4.4.3 Market size and forecast
  4.4.4 Conventional EP diagnostic catheters
    4.4.4.1 Market size and forecast
    4.4.4.2 Fixed diagnostic catheters
      4.4.4.2.1 MARKET SIZE AND FORECAST
    4.4.4.3 Steerable diagnostic catheters
      4.4.4.3.1 MARKET SIZE AND FORECAST
  4.4.5 Advanced EP diagnostic catheters
    4.4.5.1 Market size and forecast
  4.4.6 Ultrasound EP diagnostic catheters
    4.4.6.1 Market size and forecast
4.5 Access devices
  4.5.1 Key market trends
  4.5.2 Key growth factors and opportunities
  4.5.3 Market size and forecast
4.6 Others
  4.6.1 Key market trends
  4.6.2 Key growth factors and opportunities
  4.6.3 Market size and forecast

CHAPTER 5 WORLD ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2014-2022

5.1 Overview
  5.1.1 Market size and forecast
5.2 Atrial Fibrillation
  5.2.1 Market size and forecast
5.3 Atrial Flutter
  5.3.1 Market size and forecast
5.4 Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
  5.4.1 Market size and forecast
5.5 Wolff-Parkinson-White Syndrome (WPW)
  5.5.1 Market size and forecast
5.6 Others
  5.6.1 Market size and forecast

CHAPTER 6 WORLD ELECTROPHYSIOLOGY MARKET, BY GEOGRAPHY, 2014-2022

6.1 Overview
  6.1.1 Market size and forecast
6.2 North America
  6.2.1 Key market trends
  6.2.2 Key growth factors and opportunities
  6.2.3 Market size and forecast
    6.2.3.1 U.S. Market size and forecast
    6.2.3.2 Canada Market size and forecast
    6.2.3.3 Mexico Market size and forecast
6.3 Europe
  6.3.1 Key market trends
  6.3.2 Key growth factors and opportunities
  6.3.3 Market size and forecast
    6.3.3.1 Germany Market size and forecast
    6.3.3.2 France Market size and forecast
    6.3.3.3 U.K. Market size and forecast
    6.3.3.4 Italy Market size and forecast
    6.3.3.5 Rest of Europe Market size and forecast
6.4 Asia-Pacific
  6.4.1 Key market trends
  6.4.2 Key growth factors and opportunities
  6.4.3 Market size and forecast
    6.4.3.1 India Market size and forecast
    6.4.3.2 China Market size and forecast
    6.4.3.3 Japan Market size and forecast
    6.4.3.4 Australia Market size and forecast
    6.4.3.5 Rest of Asia-Pacific Market size and forecast
6.5 LAMEA
  6.5.1 Key market trends
  6.5.2 Key growth factors and opportunities
  6.5.3 Market size and forecast
    6.5.3.1 Brazil Market size and forecast
    6.5.3.2 Argentina Market size and forecast
    6.5.3.3 Egypt Market size and forecast
    6.5.3.4 IsraelMarket size and forecast
    6.5.3.5 South Africa Market size and forecast
    6.5.3.6 Rest of LAMEA Market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1 Abbott Laboratories
  7.1.1 Company overview
  7.1.2 Company snapshot
  7.1.3 Operating business segments
  7.1.4 Business performance
  7.1.5 Key strategic moves and developments
7.2 Johnson & Johnson
  7.2.1 Company overview
  7.2.2 Company snapshot
  7.2.3 Operating business segments
  7.2.4 Business performance
  7.2.5 Key strategic moves and developments
7.3 Microport Scientific Corporation
  7.3.1 Company overview
  7.3.2 Company snapshot
  7.3.3 Operating business segments
  7.3.4 Business performance
  7.3.5 Key strategic moves and developments
7.4 Boston Scientific Corporation
  7.4.1 Company overview
  7.4.2 Operating business segments
  7.4.3 Business performance
  7.4.4 Key strategic moves and developments
7.5 St. Jude Medical, Inc.
  7.5.1 Company overview
  7.5.2 Company snapshot
  7.5.3 Operating business segments
  7.5.4 Business performance
  7.5.5 Key strategic moves and developments
7.6 Medtronic plc
  7.6.1 Company overview
  7.6.2 Company snapshot
  7.6.3 Operating business segments
  7.6.4 Business performance
  7.6.5 Key strategic moves and developments
7.7 Biotronik SE & Co. KG
  7.7.1 Company overview
  7.7.2 Company snapshot
  7.7.3 Operating business segments
  7.7.4 Key strategic moves and developments
7.8 Koninklijke Philips N.V.
  7.8.1 Company overview
  7.8.2 Company snapshot
  7.8.3 Operating business segments
  7.8.4 Business performance
  7.8.5 Key strategic moves and developments
7.9 General Electric Co.
  7.9.1 Company overview
  7.9.2 Company snapshot
  7.9.3 Operating business segments overview
  7.9.4 Business performance
  7.9.5 Key strategic moves and developments
7.10 Siemens AG
  7.10.1 Company overview
  7.10.2 Company snapshot
  7.10.3 Operating business segments
  7.10.4 Financial performance
  7.10.5 Key strategic moves and developments

List Of Tables

LIST OF TABLES

TABLE 1 COMPETITIVE LANDSCAPE IN EP MARKET
TABLE 2 WORLD EP MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 3 WORLD EP ABLATION CATHETERS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 4 WORLD EP ABLATION CATHETERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 5 WORLD EP LABORATORY DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 6 WORLD EP LABORATORY DEVICES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 7 WORLD EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 8 WORLD EP DIAGNOSTIC CATHETERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 9 WORLD ACCESS DEVICES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 10 WORLD OTHER PRODUCT TYPE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 11 WORLD EP MARKET, BY INDICATION, 20142022 ($MILLION)
TABLE 12 WORLD EP MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 16 WORLD WPW SYNDROME MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 WORLD OTHER INDICATION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 18 WORLD EP MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 19 NORTH AMERICA: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 20 NORTH AMERICA: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 21 EUROPE: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 22 EUROPE: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 23 ASIA-PACIFIC: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 24 ASIA-PACIFIC: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 25 LAMEA: EP MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 26 LAMEA: EP MARKET, BY TYPE, (2014-2022) ($MILLION)
TABLE 27 ABBOTTCOMPANY SNAPSHOT
TABLE 28 ABBOTTOPERATING SEGMENTS
TABLE 29 J&JCOMPANY SNAPSHOT
TABLE 30 J&JOPERATING SEGMENTS
TABLE 31 MICROPORTCOMPANY SNAPSHOT
TABLE 32 MICROPORTOPERATING SEGMENTS
TABLE 33 BOSTON SCIENTIFICCOMPANY SNAPSHOT
TABLE 34 BOSTON SCIENTIFICOPERATING SEGMENTS
TABLE 35 ST. JUDE MEDICALCOMPANY SNAPSHOT
TABLE 36 ST. JUDE MEDICALOPERATING SEGMENTS
TABLE 37 MEDTRONICCOMPANY SNAPSHOT
TABLE 38 MEDTRONICOPERATING SEGMENTS
TABLE 39 BIOTRONIKCOMPANY SNAPSHOT
TABLE 40 BIOTRONIKOPERATING SEGMENTS
TABLE 41 PHILIPSCOMPANY SNAPSHOT
TABLE 42 PHILIPSOPERATING SEGMENTS
TABLE 43 GECOMPANY SNAPSHOT
TABLE 44 GEOPERATING SEGMENTS
TABLE 45 SIEMENSCOMPANY SNAPSHOT
TABLE 46 SIEMENSOPERATING SEGMENTS

List Of Figures

LIST OF FIGURES

FIG. 1 WORLD EP MARKET, BY PRODUCT, 2015 VS 2022, ($MILLION)
FIG. 2 MARKET SEGMENTATION FOR EP MARKETS
FIG. 3 TOP INVESTMENT POCKETS IN WORLD ELECTROPHYSIOLOGY MARKET
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)
FIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 6 TYPES OF STRATEGIES DISTRIBUTION
FIG. 7 TOP COMPANIES AND THEIR STRATEGIES
FIG. 8 DETAILED STRUCTURE OF COMPANIES: TYPE OF STRATEGIES (20132016)
FIG. 9 DETAILED STRUCTURE OF COMPANIES: NATURE OF STRATEGIES (20132016)
FIG. 10 PORTERS FIVE FORCES ANALYSIS
FIG. 11 MARKET SHARE ANALYSIS, 2015
FIG. 12 WORLD EP CRYOABLATION CATHETER MARKET, 20142022 ($MILLION)
FIG. 13 WORLD CONVENTIONAL RF ABLATION CATHETERS MARKET, 20142022 ($MILLION)
FIG. 14 WORLD IRRIGATED ABLATION CATHETERS MARKET, 20142022 ($MILLION)
FIG. 15 WORLD MICROWAVE ABLATION SYSTEM MARKET, 20142022 ($MILLION)
FIG. 16 WORLD LASER ABLATION SYSTEM MARKET, 20142022 ($MILLION)
FIG. 17 WORLD NAVIGATIONAL ADVANCED MAPPING ACCESSORIES MARKET, 20142022 ($MILLION)
FIG. 18 WORLD 3D MAPPING SYSTEMS MARKET, 20142022 ($MILLION)
FIG. 19 WORLD EP RECORDING SYSTEM MARKET, 20142022 ($MILLION)
FIG. 20 WORLD EP X-RAY IMAGING SYSTEMS MARKET, 20142022 ($MILLION)
FIG. 21 WORLD EP REMOTE STEERING SYSTEMS MARKET, 20142022 ($MILLION)
FIG. 22 WORLD CONVENTIONAL EP DIAGNOSTIC CATHETER MARKET, 20142022 ($MILLION)
FIG. 23 WORLD FIXED DIAGNOSTIC CATHETERS MARKET, 20142022 ($MILLION)
FIG. 24 WORLD STEERABLE DIAGNOSTIC CATHETERS MARKET, 20142022 ($MILLION)
FIG. 25 WORLD ADVANCED DIAGNOSTIC CATHETERS MARKET, 20142022 ($MILLION)
FIG. 26 WORLD ULTRASOUND EP DIAGNOSTIC CATHETER MARKET, 20142022 ($MILLION)
FIG. 28 AF CASES IN U.S., 20102050 (MILLION)
FIG. 29 U.S. EP MARKET, (20142022) ($MILLION)
FIG. 30 CANADA EP MARKET, (20142022) ($MILLION)
FIG. 31 MEXICO EP MARKET, (20142022) ($MILLION)
FIG. 32 GERMANY EP MARKET, (20142022) ($MILLION)
FIG. 33 FRANCE EP MARKET, (20142022) ($MILLION)
FIG. 34 U.K. EP MARKET, (20142022) ($MILLION)
FIG. 35 ITALY EP MARKET, (2014-2022) ($MILLION)
FIG. 36 REST OF EUROPE EP MARKET, (2014-2022) ($MILLION)
FIG. 37 AGE SPECIFIC WEIGHTED PREVALENCE RATE OF AF IN CHINA, 2015 (%)
FIG. 38 INDIA EP MARKET, (20142022) ($MILLION)
FIG. 39 CHINA EP MARKET, (20142022) ($MILLION)
FIG. 40 JAPAN EP MARKET, (20142022) ($MILLION)
FIG. 41 AUSTRALIA EP MARKET, (20142022) ($MILLION)
FIG. 42 REST OF ASIA-PACIFIC EP MARKET, (20142022) ($MILLION)
FIG. 43 PREVELANCE RATE OF ATRIAL FIBRILLATION (AF) ACCORDING TO AGE AND SEX IN BRAZIL, 2015 (%)
FIG. 44 BRAZIL EP MARKET, (20142022) ($MILLION)
FIG. 45 ARGENTINA EP MARKET, (20142022) ($MILLION)
FIG. 46 AFRICA EP MARKET, (20142022) ($MILLION)
FIG. 47 ISRAEL EP MARKET, (20142022) ($MILLION)
FIG. 48 SOUTH AFRICA EP MARKET, (20142022) ($MILLION)
FIG. 49 REST OF LAMEA EP MARKET, (20142022) ($MILLION)
FIG. 54 J&J: REVENUE, 2013-2015 ($MILLION)
FIG. 55 J&J: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 56 J&J: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 57 J&J: STRATEGY SHARE, 20142015 (%)
FIG. 58 MICROPORT: REVENUE, 20132015, ($MILLION)
FIG. 59 MICROPORT: REVENUE BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 60 MICROPORT: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 61 MICROPORT: STRATEGY SHARE, 20132015 (%)
FIG. 62 BOSTON SCIENTIFIC: REVENUE, 20132015, ($MILLION)
FIG. 63 BOSTON SCIENTIFIC: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIG. 64 BOSTON SCIENTIFIC: RHYTHM MANAGEMENT REVENUE BY SUB-SEGMENT, 2015 (%)
FIG. 65 BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 66 BOSTON SCIENTIFIC: STRATEGY SHARE, 2013-2016 (%)
FIG. 67 ST. JUDE MEDICAL: REVENUE, 20132015 ($MILLION)
FIG. 68 ST. JUDE MEDICAL: REVENUE BY PRODUCT CATEGORY, 2015 (%)
FIG. 69 ST. JUDE MEDICAL: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 70 ST. JUDE MEDICAL: STRATEGY SHARE, 20142016 (%)
FIG. 71 MEDTRONIC: REVENUE, 20142016 ($MILLION)
FIG. 72 MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIG. 73 MEDTRONIC: CARDIAC AND VASCULAR GROUP NET SALES, BY SUB-SEGMENT, 2016 (%)
FIG. 74 MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIG. 75 FIG. 20 MEDTRONIC: STRATEGY SHARE, 20142016 (%)
FIG. 76 PHILIPS: REVENUE, 20132015, ($MILLION)
FIG. 77 PHILIPS: REVENUE BY SEGMENT, 2015 (%)
FIG. 78 PHILIPS: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 79 PHILLIPS: STRATEGY SHARE, 20152016 (%)
FIG. 80 GE: REVENUE, 20132015 ($MILLION)
FIG. 81 GE: REVENUE BY SEGMENT 2015 (%)
FIG. 82 GE: REVENUE BY GEOGRAPHY 2015 (%)
FIG. 83 SEIMENS: REVENUE, 2013-2015, ($MILLION)
FIG. 84 SEIMENS: REVENUE BY SEGMENT, 2015 (%)
FIG. 85 SEIMENS: REVENUE BY GEOGRAPHY, 2015 (%)